Carpal Tunnel Release vs Injections vs Splints

Understanding the Three Approaches

Carpal tunnel syndrome is nerve compression, not inflammation. That distinction matters because it explains why anti-inflammatory treatments help symptoms but do not resolve the underlying problem. The transverse carpal ligament presses on the median nerve, and only surgery physically releases that pressure.

Night Splints: The Conservative Start

Wrist splints worn at night keep the wrist in a neutral position, preventing the flexion that worsens nerve compression during sleep. Evidence shows symptom improvement in 60% to 70% of patients with mild carpal tunnel over 4 to 6 weeks. Splints cost $15 to $40 over the counter and carry no procedural risk.

The limitation: splints manage symptoms without altering disease progression. If nerve conduction studies already show moderate or severe compression, splinting alone is unlikely to prevent deterioration.

Steroid Injections: Buying Time

A corticosteroid injection into the carpal tunnel reduces swelling around the nerve and can provide dramatic short-term relief. The evidence shows 70% to 80% of patients report improvement at 4 weeks. By 6 months, roughly half have relapsed. By 12 months, the majority have returned to baseline or sought surgery.

Injections work best for: patients with recent symptom onset, pregnant patients whose symptoms may resolve postpartum, and patients who need to delay surgery for scheduling reasons. Most hand surgeons limit injections to 2 to 3 per wrist over a patient's lifetime.

Surgery: The Definitive Fix

Carpal tunnel release divides the transverse carpal ligament to decompress the median nerve. Success rates exceed 90% for symptom resolution. Two techniques exist: open release through a 2 to 3 cm palmar incision, and endoscopic release through one or two smaller incisions with a camera. Long-term outcomes are identical.

Recovery is faster than most patients expect. Grip strength returns over 6 to 12 weeks. Most office workers return to typing within 2 weeks; manual laborers typically need 4 to 6 weeks.

When Surgery Cannot Wait

Three clinical findings push surgery to the front of the line: constant numbness (not just tingling), visible thenar muscle wasting at the base of the thumb, and severely abnormal nerve conduction study results. Each of these signals ongoing nerve damage, and the longer the nerve stays compressed, the less completely it recovers after release.

A Reasonable Decision Path

For intermittent nighttime symptoms with a normal physical exam: start with a night splint for 4 to 6 weeks. If symptoms persist or worsen, consider one steroid injection. If the injection wears off or nerve studies show moderate compression, surgery is the logical next step. For patients who present with constant numbness or muscle weakness, skipping directly to surgery is not aggressive; it is appropriate.

Understanding Nerve Conduction Studies

Nerve conduction studies (NCS) and electromyography (EMG) are the objective tests that quantify median nerve compression. NCS measures how fast electrical signals travel through the nerve at the wrist. Slowed conduction velocity confirms the diagnosis and grades severity. Mild CTS shows slowed sensory conduction only. Moderate CTS shows slowed motor conduction. Severe CTS shows absent sensory responses and reduced motor amplitude, indicating axonal damage that may not fully recover even after surgical release.

These studies matter for the treatment decision because they distinguish between patients who have time to try conservative treatment and patients who are actively losing nerve function. Mild or moderate NCS findings support a conservative-first approach. Severe findings with motor involvement suggest that delay risks permanent weakness and numbness in the thumb and index finger.

Not every patient needs NCS before treatment. Classic symptoms (nighttime numbness in the thumb, index, and middle fingers that improves with shaking the hand) with positive Phalen's and Tinel's tests are sufficient for a splinting trial. NCS becomes important when symptoms are atypical, when the diagnosis is uncertain, when insurance requires documentation before authorizing surgery, or when the severity needs to be graded to guide the treatment timeline.

Bilateral Carpal Tunnel: Both Hands at Once?

CTS frequently affects both hands. Patients facing bilateral surgery often ask whether both can be done simultaneously. Most hand surgeons recommend staging: one hand first, the dominant hand if symptoms are equal, then the second hand 4 to 6 weeks later. The practical reason is that both hands in recovery at the same time makes basic daily tasks (dressing, hygiene, driving, eating) extremely difficult. Staging allows one functioning hand throughout the process.

For patients traveling abroad for surgery, staging may not be practical. Some surgeons will perform bilateral release in a single session for patients who have arranged a caregiver for the first 1 to 2 weeks. This is a reasonable option when the alternative is two international trips. Discuss it with your surgeon beforehand.

What Happens if You Do Nothing

Untreated moderate-to-severe CTS progresses. The median nerve supplies sensation to the thumb, index, middle, and half the ring finger, and motor function to the thenar muscles at the base of the thumb. Prolonged compression leads to: constant numbness (not just nighttime), loss of grip strength, difficulty with fine motor tasks (buttons, coins, jars), and visible muscle wasting at the thumb base. Once thenar atrophy is established, surgical release can relieve pain and numbness but may not restore full strength. Early treatment preserves more function. The nerve recovers best when compression is relieved before axonal damage becomes severe.